ICL Pfcf Ratio vs Payout Ratio Analysis
ICL Stock | USD 5.02 0.07 1.38% |
ICL Israel financial indicator trend analysis is infinitely more than just investigating ICL Israel Chemicals recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether ICL Israel Chemicals is a good investment. Please check the relationship between ICL Israel Pfcf Ratio and its Payout Ratio accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICL Israel Chemicals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
Pfcf Ratio vs Payout Ratio
Pfcf Ratio vs Payout Ratio Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of ICL Israel Chemicals Pfcf Ratio account and Payout Ratio. At this time, the significance of the direction appears to have no relationship.
The correlation between ICL Israel's Pfcf Ratio and Payout Ratio is 0.09. Overlapping area represents the amount of variation of Pfcf Ratio that can explain the historical movement of Payout Ratio in the same time period over historical financial statements of ICL Israel Chemicals, assuming nothing else is changed. The correlation between historical values of ICL Israel's Pfcf Ratio and Payout Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Pfcf Ratio of ICL Israel Chemicals are associated (or correlated) with its Payout Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Payout Ratio has no effect on the direction of Pfcf Ratio i.e., ICL Israel's Pfcf Ratio and Payout Ratio go up and down completely randomly.
Correlation Coefficient | 0.09 |
Relationship Direction | Positive |
Relationship Strength | Insignificant |
Pfcf Ratio
Payout Ratio
Payout Ratio is the proportion of ICL Israel Chemicals earnings paid out as dividends to shareholders. Payout Ratio is typically expressed as a percentage but can be shown as dividends paid out as a proportion of cash flow. The payout ratio is used to determine the sustainability of ICL Israel Chemicals dividend payments. A lower payout ratio is generally preferable to a higher payout ratio, with a ratio greater than 100% indicating ICL Israel Chemicals is paying out more in dividends than it makes in net income.Most indicators from ICL Israel's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into ICL Israel Chemicals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICL Israel Chemicals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. At this time, ICL Israel's Selling General Administrative is quite stable compared to the past year. Sales General And Administrative To Revenue is expected to rise to 0.07 this year, although the value of Tax Provision will most likely fall to about 309.6 M.
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 216M | 327M | 160M | 119.6M | Depreciation And Amortization | 523.9M | 481.2M | 536M | 273.3M |
ICL Israel fundamental ratios Correlations
Click cells to compare fundamentals
ICL Israel Account Relationship Matchups
High Positive Relationship
High Negative Relationship
ICL Israel fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 9.2B | 9.7B | 11.1B | 11.8B | 11.6B | 7.7B | |
Short Long Term Debt Total | 2.6B | 2.8B | 3.0B | 2.8B | 2.7B | 2.2B | |
Other Current Liab | 587M | 654M | 755M | 970M | 689.4M | 507.1M | |
Total Current Liabilities | 1.8B | 2.2B | 2.6B | 2.6B | 2.6B | 1.9B | |
Total Stockholder Equity | 3.9B | 3.9B | 4.5B | 5.5B | 5.8B | 3.1B | |
Property Plant And Equipment Net | 5.2B | 5.6B | 5.8B | 6.0B | 6.3B | 3.7B | |
Net Debt | 2.5B | 2.6B | 2.5B | 2.4B | 2.3B | 2.0B | |
Retained Earnings | 3.9B | 3.8B | 4.3B | 5.4B | 5.6B | 5.9B | |
Accounts Payable | 712M | 740M | 1.1B | 1.0B | 912M | 633.8M | |
Cash | 95M | 214M | 473M | 417M | 420M | 441M | |
Non Current Assets Total | 6.5B | 6.8B | 7.2B | 7.2B | 7.6B | 4.8B | |
Non Currrent Assets Other | 353M | 393M | 279.8M | 228M | 237M | 229.3M | |
Cash And Short Term Investments | 191M | 314M | 564M | 508M | 592M | 325.7M | |
Net Receivables | 1.2B | 883M | 1.4B | 1.8B | 1.6B | 1.2B | |
Good Will | 302M | 320M | 502M | 507M | 530M | 266.3M | |
Common Stock Shares Outstanding | 1.3B | 1.3B | 1.3B | 1.3B | 1.3B | 1.4B | |
Short Term Investments | 92M | 96M | 100M | 91M | 172M | 127.5M | |
Liabilities And Stockholders Equity | 9.2B | 9.7B | 11.1B | 11.8B | 11.6B | 7.7B | |
Non Current Liabilities Total | 3.4B | 3.4B | 3.7B | 3.4B | 3.0B | 2.6B | |
Inventory | 1.3B | 1.3B | 1.6B | 2.1B | 1.7B | 1.3B | |
Other Current Assets | 51M | 275M | 357M | 323M | 122M | 122.5M | |
Other Stockholder Equity | (62M) | (56M) | (36M) | (27M) | (26M) | (24.7M) | |
Total Liab | 5.1B | 5.6B | 6.3B | 6.0B | 5.6B | 4.5B | |
Property Plant And Equipment Gross | 5.3B | 5.6B | 12.5B | 13.0B | 13.8B | 14.5B | |
Total Current Assets | 2.7B | 2.8B | 3.9B | 4.5B | 4.0B | 2.9B | |
Accumulated Other Comprehensive Income | (439M) | (312M) | (306M) | (443M) | (338M) | (354.9M) | |
Short Term Debt | 420M | 679M | 577M | 580M | 858M | 540.4M | |
Current Deferred Revenue | 42M | 17M | 33M | 41M | 10M | 9.5M | |
Intangible Assets | 332M | 336M | 365M | 345M | 343M | 403.7M | |
Other Liab | 1.2B | 1.3B | 1.3B | 1.1B | 1.3B | 1.1B | |
Other Assets | 362M | 309M | 378M | 524M | 434.7M | 384.2M | |
Long Term Debt | 2.2B | 2.1B | 2.4B | 2.3B | 1.6B | 2.3B | |
Property Plant Equipment | 5.3B | 5.6B | 5.8B | 6.0B | 6.9B | 5.1B | |
Net Tangible Assets | 3.3B | 3.3B | 3.7B | 4.6B | 5.3B | 3.1B | |
Long Term Investments | 140M | 83M | 26M | 3M | 2M | 1.9M | |
Short Long Term Debt | 371M | 684M | 577M | 512M | 786M | 523.7M | |
Long Term Debt Total | 1.8B | 2.2B | 2.1B | 2.4B | 2.2B | 1.9B |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICL Israel Chemicals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Fertilizers & Agricultural Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICL Israel. If investors know ICL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICL Israel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.18) | Dividend Share 0.2 | Earnings Share 0.31 | Revenue Per Share 5.373 | Quarterly Revenue Growth (0.06) |
The market value of ICL Israel Chemicals is measured differently than its book value, which is the value of ICL that is recorded on the company's balance sheet. Investors also form their own opinion of ICL Israel's value that differs from its market value or its book value, called intrinsic value, which is ICL Israel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICL Israel's market value can be influenced by many factors that don't directly affect ICL Israel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ICL Israel's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICL Israel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICL Israel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.